methyl 5-n-propoxy-2-benzimidazolecarbamate,
oxibendazole,
Oxibendazole,
20559-55-1,
Oxibendazolo,
Loditac,
Filaribits Plus,
Anthelcide EQ,
Oxibendazolum,
Oxibendazolum [INN-Latin],
Oxibendazolo [INN-Spanish],
UNII-022N12KJ0X,
EINECS 243-877-7,
SKF 30310,
SK&F 30310,
methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate,
Methyl 5-propoxy-2-benzimidazolecarbamate,
MLS000069646,
Methyl 5-n-propoxy-2-benzimidazole carbamate,
022N12KJ0X,
C12H15N3O3,
N-(2-(5-Propoxybenzimidazolyl)) methyl carbamate,
5-Propoxy-2-benzimidazolecarbamic acid methyl ester,
SK&F-30310,
NCGC00018238-04,
(5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester,
SMR000058208,
2-BENZIMIDAZOLECARBAMIC ACID, 5-PROPOXY-, METHYL ESTER,
N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle [French],
Carbamic acid, (5-propoxy-1H-benzimidazol-2-yl)-, methyl ester,
DSSTox_CID_25625,
DSSTox_RID_81010,
DSSTox_GSID_45625,
Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate,
methyl N-(5-propoxy-1H-benzimidazol-2-yl)carbamate,
W-107609,
methyl (5-propoxy-1h-benzo[d]imidazol-2-yl)carbamate,
oxybendazole,
N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester,
Carbamic acid, N-(6-propoxy-1H-benzimidazol-2-yl)-, methyl ester,
AJ119,(+),
CAS-20559-55-1,
Oxibendazole [USAN:BAN:INN],
Oxibendazole [USAN:INN:BAN],
Anthelcide EQ (TN),
Oxibendazole, ~98%,
Spectrum_001699,
AC1L1IKV,
methyl 5-n-propoxy-2-benzimidazolecarbamate,
Spectrum2_001556,
Spectrum3_001951,
Spectrum4_000836,
Spectrum5_001219,
Oxibendazole (USAN/INN),
5-Propoxy-2-(methoxycarbonylamino)benzimidazole,
cid_4622,
BSPBio_003551,
KBioGR_001411,
KBioSS_002179,
MLS006011733,
DivK1c_000096,
SCHEMBL168101,
SPECTRUM1503373,
SPBio_001432,
CHEMBL1087630,
DTXSID5045625,
N-(Propoxy-5, benzimidazolyl)-2, carbamate de methyle,
BDBM31048,
CHEBI:92907,
CTK8G2219,
HMS500E18,
KBio1_000096,
KBio2_002179,
KBio2_004747,
KBio2_007315,
KBio3_002864,
KS-00000GJR,
NINDS_000096,
RAOCRURYZCVHMG-UHFFFAOYSA-N,
HMS1922A22,
HMS2090F21,
HMS2094M09,
HMS3713J18,
Pharmakon1600-01503373,
HY-B0299,
ZINC4685859,
Tox21_110844,
CCG-39334,
MFCD00133728,
NSC758459,
s1851,
STL301145,
AKOS015895323,
Tox21_110844_1,
AC-8714,
AN-7054,
CCG-220608,
CS-2333,
DB04910,
MCULE-8346438764,
NSC-758459,
IDI1_000096,
NCGC00018238-01,
NCGC00018238-02,
NCGC00018238-03,
NCGC00018238-05,
NCGC00018238-06,
NCGC00018238-07,
NCGC00018238-08,
NCGC00018238-09,
NCGC00023557-03,
NCGC00023557-04,
NCGC00023557-05,
AK322613,
AS-12166,
LS-50577,
SC-73431,
AB0011434,
AB2000332,
TL8001701,
5-propoxy-2-(carbomethoxyamino)benzimidazole,
FT-0630464,
O0499,
D05293,
methyl 5-propoxy-1H-benzimidazol-2-ylcarbamate,
AB00052350-06,
AB00052350_07,
AB00052350_08,
Oxibendazole, VETRANAL(TM), analytical standard,
559O551,
A814696,
AJ-119/34637010,
SR-01000000182,
SR-05000002065,
I06-0683,
SR-01000000182-2,
SR-05000002065-1,
BRD-K52075715-001-02-6,
BRD-K52075715-001-03-4,
BRD-K84514357-001-02-9,
Methyl (6-propoxy-1H-benzo[d]imidazol-2-yl)carbamate,
methyl N-(6-propoxy-1H-1,3-benzodiazol-2-yl)carbamate,
Oxibendazole, European Pharmacopoeia (EP) Reference Standard,
Methyl (5-Propoxy-1H-benzo[d]imidazol-2-yl)carbamate / (5-Propoxy-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester,
null,
Oxfendazole,
D0B9GM,
Oxibendazole, GlaxoSmithKline,
CID4622,
Oxibendazole, 98% - 50MG 50mg,
C12-H15-N3-O3,
CS-T-38185,
B1999,
A11654,
C011321,